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Abstract.  The protracted absence of muscle activation 
initiates complex cellular and molecular reactions 
aimed at restoring functional neuromuscular transmis- 
sion and preventing degenerative processes. A central 
aspect of these reactions is the sprouting of intramus- 
cular nerves in the vicinity of inactivated muscle 
fibers. Sprouts emerging from terminal nerve branches 
and nodes of Ranvier can reestablish functional con- 
tacts with inactive muscle fibers, and this is an essen- 
tial restorative process in pathological conditions of 
the neuromuscular system. Due to their rapid upregu- 
lation in inactive skeletal muscle fibers and their ability 
to induce nerve sprouting in adult muscle, insulin-like 
growth factors (IGFs) are candidate signaling  mole- 
cules to promote restorative reactions in the neuro- 
muscular system. In this study we have exploited the 
high affinity and specificity of IGF-binding protein 4 
(IGF-BP4) and IGF-BP5 for IGFI and IGF2 to deter- 
mine whether these growth factors are involved in the 
nerve sprouting reaction in paralyzed skeletal muscle. 
In tissue culture experiments with sensory- and 
motoneurons we demonstrate that the neurite promot- 
ing activity of IGF1 is blocked by IGF-BP4, and that a 
similar IGF-BP-sensitive activity is detected in muscle 
extracts from paralyzed, but not from control muscle. 
In in vivo experiments, we show that local delivery of 
IGF-BP4 to Botulinum toxin A-paralyzed skeletal 
muscle effectively prevents nerve sprouting in that 
muscle.  Our findings  indicate that muscle IGFs play 
an essential role in intramuscular  nerve sprouting.  In 
addition,  these findings suggest that IGFs are major 
signaling factors from inactivated muscle to promote 
local restorative reactions,  including interstitial  cell 
proliferation and nerve sprouting. 
T  t-IE neuromuscular system reacts to the prolonged ab- 
sence of muscle activation with a complex set of cel- 
lular reactions aimed at preventing degenerative  pro- 
cesses and at restoring normal activity. Knowledge about the 
molecular and cellular mechanisms  involved in these restor- 
ative reactions is important to our understanding  of the pro- 
cesses involved in neuromuscular junction development and 
maintenance.  In addition,  it is central to progress in the un- 
derstanding and treatment of pathological situations involving 
the neuromuscular system; these include peripheral  neurop- 
athies, peripheral regeneration  upon lesion, and motoneuron 
disease. 
The reactions of the neuromuscular system to functional 
inactivation  have been studied extensively  and,  as a conse- 
quence, much is known about the sequence of events in- 
volved, at the physiological,  cellular, and molecular level. At 
the macroscopic level, inactivation  leads to proliferation  of 
muscle interstitial cells (Murray and Robbins,  1982; Connor 
and McMahan,  1987; Gatchalian  et ai.,  1989),  and to in- 
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tramuscular sprouting  of the remaining  intact nerves (Hol- 
land  and Brown,  1981; Brown,  1984).  At the molecular 
level, gene expression is affected in most cells in the vicinity 
of inactive skeletal muscle fibers, including  fibroblasts,  ter- 
minal  Schwann  cells,  and  the  muscle  fibers  themselves 
(Laufer and Changeux,  1989; Gatchalian  et al.,  1989; Tsay 
and Schmid,  1990; Eftimie et al.,  1991). These local reac- 
tions are probably brought about by alterations  in the set of 
proteins exposed on the surface of the reacting cells, and by 
diffusible  factors. 
The evidence for a role of muscle-derived diffusible  fac- 
tors in the reactions  of the neuromuscular system to func- 
tional inactivation is mostly circumstantial.  Thus a stimulus 
for  intramuscular  nerve  sprouting  probably  spreads  for 
,'-,100/zm from inactivated neuromuscular junctions (Brown 
et al., 1980; Slack and Pockett, 1981; Kuflter, 1989). Local 
proliferation  of muscle interstitial  cells, mainly in the vicin- 
ity of inactivated  neuromuscular junctions,  is likely to be 
triggered by muscle-derived diffusible activities, since an ex- 
tensive basal lamina probably prevents direct surface inter- 
actions between inactivated muscle fibers and nearby inter- 
stitial cells.  Finally,  substantially  elevated levels of neurite 
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protein extracts from paralyzed skeletal muscle (Henderson 
et al.,  1983). 
While the cellular source of these activities need not exclu- 
sively be the skeletal muscle fiber, it is clear that the signal(s) 
that initiate the restorative reactions must come from the in- 
activated muscle fibers. 
Candidate muscle-derived signaling factors whose expres- 
sion is upregulated by muscle inactivation include the insulin- 
like growth factors IGF1 and IGF2 (Ishii,  1989; Rechler and 
Nissley,  1990; Caroni and Schneider,  1994). There is sub- 
stantial evidence suggesting that IGFs may be muscle-derived 
factors affecting the responses of the neuromuscular system 
to functional  inactivation.  Thus their expression  is rapidly 
upregulated  in  Botulinum  toxin  paralyzed  or  denervated 
skeletal  muscle (Ishii,  1989; Caroni and Schneider,  1994). 
Elevated  levels of IGFI mRNA were detected as early as 
15 h after paralysis and peak levels were reached after about 
36 h (Caroni  and Schneider,  1994).  Similar  findings were 
obtained for the corresponding protein.  IGF1 induction  in 
skeletal muscle therefore parallels that of the myogenic tran- 
scriptional regulators MyoD1 and myogenin and of the t~-sub- 
unit  of  the  nicotinic  acetylcholine  receptor  (Tsay and 
Schmid,  1990; Eftimie et al.,  1991; Caroni and Schneider, 
1994). It precedes or coincides with the interstitial  cell pro- 
liferation  reaction, one of the earliest macroscopieally de- 
tectable cellular reactions in paralyzed muscle (Murray and 
Robbins,  1982; Connor and McMahan,  1987; Gatchalian et 
al.,  1989). In skeletal muscle, IGF1 receptors are found on 
muscle fibers, fibroblasts,  and motoneurons, indicating that 
these ceils could be affected by the elevated levels of IGFs 
that are induced upon muscle inactivation  (Shimizu  et al., 
1986; ToUefsen et al.,  1989; Lewis et al.,  1993). Further- 
more, we have recently demonstrated that a signaling path- 
way involving IGF1 does operate from skeletal muscle to spi- 
nal motoneuron cell body (Caroni  and Becker,  1992). This 
signaling pathway can affect the downregulation of motoneu- 
ron growth-associated  proteins in neonatal rats at the time 
of synapse elimination.  Finally, elevating the levels of intra- 
muscular IGFs in adult skeletal muscle by local subcutaneous 
injections  is sufficient to stimulate local interstitial  cell pro- 
liferation  and nerve sprouting  (Caroni  and Grandes,  1990; 
Lewis et al.,  1993). 
The biology of the IGFs is affected by highly specific bind- 
ing proteins that  bind to and modulate the activity of the 
growth factors in the extracellular  space (Froesch et al., 
1985; Baxter and Martin,  1989; Clemmons,  1990; Rechier 
and Nissley,  1990;  Rosenfeld et al.,  1990;  Shimasaki  and 
Ling,  1991). The IGF-binding  proteins (IGF-BPs)  used in 
this  study,  i.e.,  IGF-BP4 and IGF-BP5 bind to IGFI  and 
IGF2 with undistinguishable  affinity (Kiefer et al.,  1989). 
Corresponding K^ values determined in vitro with purified 
recombinant components were 10--100-fold  higher than that 
of the IGF1 receptor for IGF1 and IGF2 (Kiefer et al., 1992). 
In biological assays with cultured ceils, the inclusion of a 10- 
fold molar excess of IGF-BP over IGF is sufficient to block 
mitogenic and differentiation activities of the IGFs (Kiefer et 
al., 1992). In addition, IGF-BP4 and IGF-BP5 do not appear 
to bind with biologically relevant affinities to known growth 
factors other than IGF1 or IGF2 (Baxter and Martin,  1989; 
Clemmons,  1990;  Rosenfeld et al.,  1990;  Shimasaki  and 
Ling,  1991). Therefore, these IGF-BPs are highly potent and 
specific naturally  occurring ligands of IGFs. As such, they 
may potentially  be applied to specifically interfere  with the 
actions of IGFs in vitro, and possibly also in vivo. 
In the present study we have taken advantage of the strong 
and specific interaction  between the IGFs and IGF-BP4 (or 
IGF-BP5) to determine whether muscle IGFs are involved in 
nerve sprouting  in inactivated  skeletal  muscle.  We report 
that the neurite outgrowth promoting  activity in soluble pro- 
tein extracts  from paralyzed skeletal  muscle is neutralized 
when IGF-BPs are included in the culture medium.  In addi- 
tion,  local release of IGF-BP4 from an osmotic minipump 
implanted  subcutaneously .over  paralyzed  mouse  gluteus 
muscle prevented  intramuscular  nerve sprouting.  Together 
with our previous finding that locally applied IGF-BP5 pre- 
vents interstitial cell proliferation  in paralyzed skeletal mus- 
cle (Caroni  and Schneider,  1994),  our results  indicate that 
muscle IGFs are a central  component of signaling in inacti- 
rated muscle.  In addition,  our findings suggest that muscle- 
derived IGFs play an essential  role in the nerve sprouting 
reaction in paralyzed skeletal  muscle. 
Materials and Methods 
Reagents 
Human recombinant IGF-BP4 and IGF-BP5  were expressed  in yeast and 
purified as described previously  CKiefer et al.,  1992). For stock solutions, 
the IGF-BPs were dissolved at 100-300 #g/ml in PBS with 0.1% BSA; these 
solutions were then filtered through a sterile 0.22-~tm filter and stored for 
periods of up to 2 months at 4°C.  Purified Botulinum toxin A was a kind 
girl of V.  Witzemann, Max Planck Institute,  Heidelberg,  FRG.  Human 
recombinant  IGFI was a kind gift of J. Fischer, University of Zfirich, Swit- 
zerland. The IGF1  derivative loug3R-IGF1 was from GroFop,  Adelaide, 
Australia.  In contrast to IGF1, it binds poorly to IGF-BPs,  and displays 
elevated potency in in vitro and in vivo experiments.  Mouse jSNGF and 
bFGF were from Boehringer-Mannheim. Rat recombinant ciliary neuro- 
trophic factor (CNTF) 1 was from Preprotek Inc., Rocky Hill, NJ. Purified 
brain-derived neurotrophic factor (EDNF)  was  a  kind gift from Y.-A. 
Barde, Max Planck Institute for Psychiatry, Munich, FRG. Monoclonal an- 
tibody to 160-kD neurofilament  protein was from Sigma Chem. Co.  (St. 
Louis,  MO).  Biotin-conjugated  goat-anti-mouse,  and  lucifer  yellow- 
conjugated streptavidin were from Molecular Probes (Eugene, OR). Lami- 
nin was purchased from Collaborative Research  (Bedford,  MA). ALZET 
osmotic  minipumps  (model  10071))  were  from  ALZA  Corp.  (Palo 
Alto, CA). 
In Vivo  Experiments 
20-25 g Balb/C mice were paralyzed locally with a single injection of 25 
pg of Botulinum toxin A (Thesleff,  1989) into one gluteus muscle.  Local 
paralysis developed within 24 h and lasted for at least 10 d. The extent of 
paralysis varied somewhat between animals: while most animals did retain 
some residual motility of the paralyzed leg, no toxin-treated animal was free 
of  obvious signs of local paralysis when the toxin was applied at this dosage. 
When indicated, osmotic minipumps (1.5-cm length; inner volume of 100 
#l; rate of delivery: II #l per day) were implanted subcutaneously  over the 
giuteus muscle just before application of the Botulinum toxin. 
Attention was  paid to the positioning of the minipump: this was im- 
planted anterior relative to the giuteus muscle, parallel to the body axis, 
,~0.5-1  cm laterally from the vertebrae column,  and with its opening 
slightly anterior of the femur. Handling of the pumps was according to the 
recommendations of the manufacturer.  For most experiments, IGF-BPs 
were diluted to a final concentration of 100/~g/ml in PBS with 0.1% BSA. 
In most cases, the position of the pump did not change in an obvious manner 
during the course of the experiment. 7 d aP~er initiation of the experiments 
1. Abbreviations  used in this paper: BDNF, brain-derived neumtrophic fac- 
tor; CNTF,  ciliary neurotrophic factor; E, embryonic day; DRG,  dorsal 
root ganglia; IGF, insulin-like  growth factor; IGI~BP, IGF-bindiug  protein. 
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pump during the experiment verified by visual inspection, as recommended 
by the manufacturer. None of  the osmotic minipumps appeared to have mis- 
functioned. 
Because IGF-BPs are very stable at 37"C, no attempts were made to 
verify that the binding proteins in the minipumps were still active at the end 
of the experiment. For the combined silver esterase reaction,  dissected 
gluteus muscles were maintained for 5 rain in PBS with 5 mM EDTA, 
mounted for cryosectioning,  and processed as described (Pestronk and 
Drachman, 1978).  A section thickness of 50 pan was found to yield repro- 
ducible results with respect to reliable staining of terminal branches and 
sprouts. At least ten sections per muscle were processed and analyzed. 
Three  evenly  stained  sections per  muscle were  further  analyzed at  a 
magnification of 500×. To determine the fraction of endplates with sprouts, 
all endplates from randomly selected fields were analyzed. Endplntes with 
at least one sprout that dearly emerged from the endplate region and was 
longer than 5 #m were scored as positive. At least 100 endplates per muscle 
were analyzed, and values in Fig. 5 are the mean and standard deviation 
from five independent animals. Lengths of terminal sprouts were estimated 
with Image 1.4 (NIH) software. Briefly,  an axiovert 10 microscope (Carl 
Zeiss, AG) was connected to a Macintosh llcx computer through a S/W- 
CCD  camera  (model BC-2,  AVT-Horn).  Sprouts were treated as two- 
dimensional structures, and a total of at least 50 terminal sprouts from ran- 
domly selected fields were analyzed per muscle. Values in Fig. 5 are means 
and standard deviations from five independent animals. Where indicated, 
endplate areas were estimated by calculating ellipse areas from largest and 
smallest diameters, as deduced from data like those shown in Fig. 4. In this 
case, values are means and standard deviations from three independent 
animals (total of 75 endplates). 
Soluble protein fractions from mouse glutens muscles were prepared 4 
d after initiation of the various treatments, as described (Henderson et al., 
1983).  Briefly,  muscles were homogenized with a  polytron in ice-cold 
calcium- and magnesium-free Hanks with 5 mM EDTA;  100,000  g  (1 11) 
supernatants were collected. Protein concentrations were adjusted to  1 
mg/ml and extracts were stored at -20"C. The 4-d interval between initia- 
tion of the treatment and collection of the muscles was selected based on 
the assumption that extracts may then contain highest levels of neurite- 
promoting activity (Henderson et al.,  1983). 
Cell Culture Experiments 
Dissociated embryonic day (E) 8 chick dorsal root ganglia (DRG) neurons 
were isolated by a standard protocol. Briefly, ganglia were exposed to tryp- 
sin,  and  dissociated;  cells were  washed and plated  at  low density on 
lamlnln- and polyornithine-coated glass coverslips in DMEM with 10% 
FCS and 2 ng/ml of NGF. Where indicated, muscle extracts (1/~g/ml, final 
concentration), IGF-BPs, and long3R-IGF1  were diluted into the culture 
medium at the time of plating. E6 chick and El5 rat spinal motoneurons 
were purified and cultured as described (Henderson et al., 1993;  Camu et 
al., 1993).  Chick motoneurons were cultured in enriched L15 in the pres- 
ence of 2% horse serum, 2 ng/ml CNTF, and 10 ng/ml bFGF (Arakawa et 
al.,  1990;  Camu et al.,  1993).  For rat motoneurons, the culture medium 
was  supplemented with  2  ng/ml  of BDNF  (Henderson et  al.,  1993). 
Motoneurons were plated at a density of '~ 3,000 cells per 35-ram culture 
dish. For most experiments with DRG neurons, cultures were fixed in 4 % 
paraformaldehyde 3 h after plating, and processed for immunocytocbemis- 
try as described (Widmer and Caroul,  1993).  GAP-43 immunoreactivity 
was detected by incubation with the specific monoclonal antibody 5F10, fol- 
lowed by goat-anti-mouse biotin, and lucifer yellow-streptavidin, as de- 
scribed (Widmer and Caronl,  1993). 
Neurite lengths were measured from photographs of stained (GAP-43, 
DRG neurons; neurofilament-160, chick motuneurons) or living (rat and 
chick motoneurons) cultures, using NIH Image 1.4 software. All neurons 
from  randomly  selected  fields  (250×  [DRG]  or  60×  [motoneurons] 
magnification) with at least one neurite longer than a cell diameter were ana- 
lyzed. Neurite length was defined as a neuron's longest neurite. In 3 h DRG 
cultures, most neurons had grown several neurites of comparable length. 
50 neurons were analyzed per experiment and values in Fig.  1 and Table 
I are averages and standard deviations from the pooled data of 4 (DRG) or 
3 (motoneurons) independent experiments. For 2 d, motoneuron survival 
values, all cells with neurites in 35-ram culture dishes were counted (two 
determinations, average value given in Table  I).  Growth cone areas and 
number of branch points per 100 pin were estimated from data like those 
shown in Fig. 2, a-c. All neurons from randomly selected fields whose neu- 
rites and growth cones could be assigned unambiguously were analyzed. 
For branch point per 100 ~m values, all primary neurites (longest distance 
Table L  Suppression by IGF-BP4 of an Activity in 
Protein Extracts from Paralyzed Muscle That Stimulates 
Neurite Outgrowth from Cultured Chick and Rat 
Spinal Motoneurons 
Muscle extract  Neuron numbers  Neurite  length (~m) 
no BP  +IGF-BP4  no BP  +IGF-BP4 
Chick motoneurons 
none  1081  1185  415  +  145  470  +  155 
control muscle  1202  1151  580  +  167  560  +  151 
paralyzed muscle 1010  1186  1012  +  305  606  +  186 
Rat motoneurons: 
none  1452  1514  365  +  111  337  5:108 
control muscle  1397  1470  399  +  138  371  +  131 
paralyzed muscle 1597  1545  853  +  276  390  5:115 
Approximately  3,000 purified spinal motoneurons were plated onto laminin- 
coated 35-mm culture dishes and 2-d cultures were analyzed.  Neuron number 
values are averages from two independent experiments. Neurite length values 
are averages and standard deviations  (total of 100 neurons from two indepen- 
dent experiments).  100 ng/ml of IGF-BP4 specifically suppressed the neurite- 
promoting activity in 1 ~,g/ml of protein extract from paralyzed muscle (17 < 
0.0005;  Student's t test). Note that the binding protein did not detectably affect 
2 d motoneuron survival  in the presence of CNTF and bFGF (chick moto- 
neurons), or BDNF (rat motoneurons).  Also note that the binding protein did 
not significantly affect basal neurite outgrowth in the absence or in the presence 
of muscle extract from untreated  control muscle. 
from cell body to neurite tip) were analyzed. Values are means and standard 
deviations from 100 neurons (two independent experiments). 
Results 
A Paralysis-induced Neurite Outgrowth Promoting 
Activity in Soluble Protein Fractions  from Muscle Is 
Blocked by IGF-BP4 
In a first series of experiments, we determined whether IGF- 
BPs may counteract the effects of IGFs on cultured neurons, 
and whether extracts  from paralyzed muscle  may contain 
IGF-BP-sensitive  activities.  IGFs are known to effectively 
promote neurite outgrowth in vitro when tested at concentra- 
tions as low as 100 pM. Neurons responsive to IGFs in neu- 
rite outgrowth assays include sympathetic, sensory, and moto- 
neurons  (Recio-Pinto  et  al.,  1986;  Caroni  and  Grandes, 
1990).  As  shown in Fig.  1 A,  500 pM of purified human 
recombinant IGF1  effectively accelerated the initial rate of 
neurite outgrowth from dissociated E8 chick DRG neurons 
cultured on a laminin-coated substratum in the presence of 
2 ng/ml of NGE These concentrations of NGF are saturating 
with respect to the survival of DRG neurons, and the laminin 
presumably provided optimal substratum conditions for these 
neurons. The figure also shows that a 10-fold molar excess of 
purified recombinant human IGF-BP4 over IGF1 completely 
abolished the effect of the IGF on neurite outgrowth. On the 
other hand, no effects  of IGF-BP4 on neuron numbers could 
be detected, in agreement with its inability to bind to NGE 
One to two months old mice were treated locally with a 
single 25 pg dose of purified Botulinum toxin A. The toxin 
was applied into one glutens muscle,  thus producing com- 
plete and lasting local paralysis. Four days after toxin treat- 
ment, animals were sacrificed and protein extracts from the 
paralyzed and from the control contralateral gluteus muscle 
were prepared. These were tested in the neurite outgrowth 
assay at protein concentrations of 1 #g/ml. As shown in Fig. 
l(A3), the extract from the paralyzed muscle was approxi- 
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of IGFI by IGF-BP4, and demonstration of  IGF-BP4-sensitive neu- 
rite promoting activity in protein extracts from paralyzed muscle. 
Dissociated  E8  chick DRG neurons  were plated  on a  laminin- 
coated substratum in the presence of 2 ng/ml of NGE Cells were 
fixed 3 h after plating and the average length of a neuron's longest 
neurite was determined.  (A and B) Neurons cultured without (A) 
and with (B) 100 ng/ml of IGF-BP4. Further additions to the cul- 
ture medium were: (1) no additions; (2) 1 #g/ml of  soluble proteins 
from control adult mouse gluteus muscle;  (3) 1/~g/ml of protein 
extract  from gluteus  muscle  4  d  after paralysis  with Botulinum 
toxin A; (4) 0.5 nM IGFI. Average values and corresponding stan- 
dard deviations are given in the figure (total of 200 neurons ana- 
lyzed per value; from four independent experiments with 50 neu- 
rons per experiment).  A3 and A4 are significantly different from 
A1  and  A2  and  B1-4 (p <  0.0005;  Student's t test).  (C) Dose- 
dependent inhibition of the neurite-promoting activity in a protein 
extract from paralyzed  muscle by IGF-BP4 (experimental condi- 
tions as in A3). The final concentrations of added IGF-BP4 were 
(1) none; (2) 2 ng/ml; (3) 5 ng/ml; (4) 10 ng/ml; (5) 25 ng/ml; (6) 
100 ng/ml; (7) 200 ng/ml; 8,500 ng/ml. Values are the average of 
two independent experiments (50 neurons per experiment).  1 nM 
IGF-BP4 corresponds  to '~25 ng/ml. 
mately as effective as 500 pM IGF1 in stimulating neurite 
outgrowth in the DRG neuron assay. In contrast, no stimula- 
tion over the rate induced by 2 ng/ml of NGF was detected 
in the presence of 1 #g/nil of extracts from contralateral, 
non-paralyzed muscle, or from the gluteus muscle of an un- 
treated animal.  This finding is in agreement with previous 
reports that demonstrated the presence of elevated contents 
of neurite outgrowth promoting activity in soluble protein 
extracts from denervated muscle (Henderson et al.,  1983). 
While earlier data were produced with mixed spinal cord- 
derived neuronal cultures, our findings now demonstrate that 
activities acting on chick DRG neurons are also present in 
the extracts from inactivated mouse muscle. 
The data of Fig. 1 demonstrate that the neurite-promoting 
activity in the extract from paralyzed muscle could be neu- 
tralized by IGF-BP4 in a dose-dependent manner. 100 ng/ml 
of IGF-BP4 were sufficient to neutralize the activity present 
in 1 #g/ml of protein extract. The blocking activity was not 
restricted to IGF-BP4,  since  100 ng/ml of human recom- 
binant IGF-BP5 were equally effective in neutralizing the ac- 
tivity present in the muscle extract (data not shown).  From 
these experiments we conclude that under our experimental 
conditions the neurite-promoting activity detected in soluble 
protein extracts from paralyzed mouse skeletal muscle de- 
pends on,  and is probably due to IGFs. 
Protein extracts from paralyzed muscle not only acceler- 
ated the initial outgrowth of neurites from DRG neurons, but 
also produced striking effects on neurite and growth cone 
morphology. As shown in Fig. 2,  DRG neurons grown for 
24 h in the presence of extract from paralyzed muscle had 
larger growth cones (average area:  164  +  38 #m  2) and more 
branched neurites (5.4 +  1.2 branchpoints per 100 #m) than 
their counterparts in the presence of extract from non-para- 
lyzed muscle (growth cone area: 32  +  15 #m2; branchpoints 
per 100 #m:  1.9  +  0.5).  Significantly, this effect of the ex- 
tract from paralyzed muscle was abolished when 100 ng/ml 
of IGF-BP4 were included in the culture medium (Fig. 2 c; 
with IGF-BP4:  growth cone area:  45  +  16  #m2;  branch- 
points per 100 #m: 2.1  +  0.6).  On the other hand, IGF-BP4 
had no apparent effects when neurons were grown in the pres- 
ence of extract from control muscle (Fig. 2 b; with IGF-BP4: 
29 +  14 #m  2 and 2.2  +  0.7 branchpoints per 100 #m) or of 
NGF alone (Fig. 2 a; 29  +  17 #m  2 [no IGF-BP4] and 27  5: 
15/zm  2 [with IGF-BP4]; 1.8  +  0.7 [no IGF-BP4] and 2.0  5: 
0.5  [with IGF-BP4] branchpoints per  100 #m). Therefore, 
muscle extracts from paralyzed mouse skeletal muscle con- 
taln activities promoting the growth, spreading, and branch- 
ing of neurites from chick DRG neurons, and these activities 
are suppressed by IGF-BPs. 
The IGF-BP-sensitive effect of protein extracts from para- 
lyzed muscle on neurite outgrowth could also be detected 
with cultured chick and rat spinal motoneurons. As shown 
in Fig. 3 and Table I, 100 ng/ml of IGF-BP4 effectively sup- 
pressed the neurite-promoting activity in 1/zg,/ml of protein 
extract from paralyzed muscle. Importantly, IGF-BP4 had 
no effect on neurite outgrowth in the absence of muscle ex- 
tract. In addition, IGF-BP4 did not detectably affect moto- 
neuron  survival under any of the experimental conditions 
tested, including where no muscle extract was added to the 
culture medium. Under such experimental conditions more 
than 60% of the motoneurons die in the absence of appropri- 
ate survival-promoting factors (Arakawa et al.,  1990; Hen- 
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cle  extract  from  paralyzed 
muscle on neurite and growth 
cone morphology is suppres- 
sed  by  IGF-BP4.  E8  chick 
DRG neurons  were  cultured 
for 20 h (a-c) and 3 d (d) in 
the  absence  (left)  or  in  the 
presence (right) of 100 ng/ml 
of IGF-BP4.  Photographs  of 
indirect  immtmofluorescence 
labeling for the neuronal pro- 
tein GAP-43 are shown in the 
figure. GAP-43 immunocyto- 
chemistry  reliably  visualizes 
neuritic  morphology,  includ- 
ing growth cones  and ftiopo- 
dia (Allsopp and Moss, 1989; 
Widmer  and  Caroni,  1993). 
Other experimental conditions 
were as in Fig. L Additions to 
the  culture  medium:  (a)  no 
muscle extract; (b) I ttg/ml of 
extract  from control  muscle; 
(c and d)  1 ~g/ml of extract 
from paralyzed  muscle. Note 
strikingly larger growth cones 
(arrows in c, left) in the pres- 
ence of  extract from paralyzed 
muscle,  in  the  absence,  but 
not  in  the  presence  of  100 
ng/ml of  IGF-BP4 (see Results 
section for quantitative analy- 
sis).  Also note that the IGF- 
BP4  interfered  with  neuritic 
branching, but not with NGF- 
dependent  DRG neuron  sur- 
vival  in  3  d  cultures  (d). 
Bar, 45 t~m. 
derson et al.,  1993).  Chick motoneurons were cultured in 
the presence of CNTF and bFGF (Arakawa et al.,  1990), 
whereas  rat  motoneurons  were  maintained  with  BDNF 
(Henderson et al., 1993). Therefore, under our experimental 
conditions, IGF-BP4 did not detectably interfere with the ac- 
tivity of NGF (Figs.  1 and 2), BDNF, or CNTF plus bFGE 
These findings are further evidence for the high specificity 
of IGF-BP4 for IGF1 and IGF2. 
In summary, our experiments demonstrate that the puri- 
fied human recombinant IGF-BPs used in this study can be 
applied to specifically neutralize the neurite-promoting ac- 
tivities of purified IGFs and of complex protein extracts from 
paralyzed mouse muscle under primary culture conditions, 
suggesting that they may also block these activities when ap- 
plied in excess in vivo. 
IGF-BP4 Prevents Intramuscular Nerve Sprouting in 
Paralyzed Mouse Gluteus Muscle 
To determine whether muscle IGFs are involved in the nerve 
sprouting reaction in paralyzed muscle we delivered purified 
human recombinant IGF-BP4 to mouse gluteus muscle that 
had been exposed to a paralyzing dose of Botulinum toxin 
A (Thesleff, 1989). The IGF-BP4 was released for 7 d at an 
estimated rate of 1/~g/day from an osmotic minipump im- 
planted subcutaneously over the paralyzed muscle. Botuli- 
num toxin A was applied shortly before implantation of the 
osmotic minipump. The dose of IGF-BP4 was selected by as- 
suming a maximal muscle interstitial space concentration of 
IGFs of 100 ng/rrd. This value is probably never reached in 
muscle,  and  it corresponds  to  the  tissue content  of IGFs 
found in the liver, i.e., the site with the highest contents of 
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neurite-promoting activity in 
extracts from paralyzed mus- 
cle by IGF-BP4. Chick (upper 
four panels) or rat (lower two 
panels)  spinal motoneurons 
were  plated  on  a  laminin- 
coated substratum in the pres- 
ence of  2 % horse serum and 2 
rig/m1 CNTF plus  10 ng/n~ 
bFGF  (chick motoneurons  ), 
or 2 ng/ml BDNF (rat moto- 
neurons). Where indicated, 1 
ttg/ml of protein extract from 
paralyzed muscle and/or  100 
ng/ml IGF-BP4 were also in- 
cluded in  the  culture  medium. 
(Chick motoneurons) 2 d cul- 
tures;  neurofilament-160 im- 
munoreactivity  visualized 
with  alkaline  phosphatase 
color reaction. (Rat motoneu- 
rons) 2 d cultures; phase con- 
trust  photographs  of unfixed 
ceils. Note effect of IGF-BP4 
on neurite length in the pres- 
ence of  extract from paralyzed 
muscle.  Also  note  lack  of 
effect of IGF-BP4 on neuron 
numbers and on neurite length" 
in the absence of muscle ex- 
tract (see Table I for quantita- 
tive  analysis).  Bar,  400 /~m 
(upper four panels); 200 #m 
(lower two panels). 
IGFs in the body. The gluteus muscle system has proven to 
be  particularly  convenient  in  previous,  similar  studies 
(Brown,  1984,  Caroni and Grandes,  1990; Gurney et al., 
1992):  it is superficial and only 4-5 muscle fibers across, 
thus facilitating the diffusion of agents from the subcutane- 
ous space. 
As shown in Fig. 4 b, and in agreement with previous 
reports  (Holland  and  Brown, 1981),  extensive  nerve sprout- 
ing  was detected  in  the  gluteus  muscle of  animals 7 d after 
toxin application.  Significantly,  however,  essentially  no 
sprouts  were detected  in  IGF-BP4-trcated animals (Fig.  4, 
c-eL The  figure  also  shows  that  subcutaneous application  of 
long 3R-IGFI  over the gluteus muscle of otherwise un- 
treated  animals also  induced nerve sprouting,  although less 
effectively than Botulinum toxin A. The most reliable effect 
of this IGFI  derivative with reduced binding to IGF-BPs, 
however, was a marked increase in the size and complexity 
of  the terminal nerve branches at the neuromuscular  junction 
(Fig.  3 f, estimated average endplate areas of 530  +  149 
sm  2 [control] and 1099  +  251/.tm  2 [with IGF1]). A .quail- 
titative  analysis  of the  effects of IGF-BP4  on  paralysis- 
induced sprouting is shown in Fig.  5.  The results demon- 
strate that frequency  and median length of  the sprouts emerg- 
ing  from  neuromuscular junctions  of paralyzed  muscles 
were dramatically reduced by IGF-BP4. In fact, sprouting 
values in the presence of the IGF-BP4 were only slightly 
higher than those detected in control non-paralyzed muscles 
(data not shown). The data also show that sprouting inhibi- 
tion was due to the presence of the IGF-BP4 in the osmotic 
minipump, since in control experiments minipumps contain- 
ing only carrier did not affect the sprouting reaction. In addi- 
tion, when an osmotic minipump was applied over the contra- 
lateral  non-paralyzed  muscle,  no interference  with  sprouting 
in the ipsilateral muscle was detected, arguing against a sys- 
temic mode of action of the IGF-BP4 in these experiments. 
We did not test systematically the dose-response of IGF- 
BP4 in  the  sprouting  experiment in  vivo,  because of the 
potential difficulties in the interpretation of the experiment 
due to in vivo diffusion of limiting amounts of binding pro- 
tein. We did, however, notice that delivery of 100 ng of  IGF- 
BP4 per day, i.e., a 10-fold lower dose significantly reduced 
the inhibitory effect on the sprouting response,  indicating 
that the experimental conditions selected in our experiments 
were probably near to  opthnal.  In  conclusion,  therefore, 
these  experiments  demonstrate  that  IGF-BP4  specifically 
suppresses  the intramuscular  nerve sprouting  reaction in 
paralyzed mouse  skeletal  muscle,  indicating  that  muscle 
IGFs are required for this process. 
Discussion 
We have shown that the neurite outgrowth-promoting activ- 
ity of  IGFs in vitro can be specifically blocked by the applica- 
tion of IGF-BP4. Using the same in vitro assay,  we demon- 
strate that soluble protein extracts from paralyzed, but not 
from control adult mouse muscle contain substantial amounts 
The Journal of Cell Biology, Volume 125,  1994  898 Figure 4. Suppression of  terminal nerve sprouting in paralyzed mouse gluteus muscle in the presence of IGF-BP4. Combined silver esterase 
stainings of mouse gluteus muscle cryostat sections are shown in the figure.  Muscle treatments: (a) control, untreated muscle; (b-e) 7 
d  after Botulinurn toxin A-induced paralysis, with  (b) and with (c-e) IGF-BP4; (f) daily local subcutaneous injections of 100 ng of 
long3R-IGFl for 7 d. The white "v'-symbols point to the position of some of the neuromuscular junctions in the photographs; black ar- 
rows point to examples of sprouts in b and f. IGF-BP4 was delivered from an osmotic minipump implanted subcutaneously over the para- 
lyzed muscle, as described in the Materials and Methods section. The estimated rate of delivery was "ol pg of IGF-BP4 per day. Note 
presence of extensive terminal nerve sprouts in b, and absence of sprouting in the IGF-BP4-treated and paralyzed muscles in c, d, and 
e. Also note enlargement of the endplates (estimated average areas: 530 -1- 149 ~m  2 (untreated), 1099  +  251 pm  2 [IGFl-treated]), pres- 
ence of swellings  in terminal nerve branches, and occasional sprouts in the presence of the IGF1 derivative (f). Bar, 50 #m. 
of IGF-BP4-sensitive neurite outgrowth-promoting  activity. 
When  applied  in vivo,  IGF-BP4 effectively suppressed  ila- 
tramuscular  nerve sprouting  in Botulinum  toxin paralyzed 
mouse muscle.  Our findings therefore indicate that muscle 
IGFs are required  for nerve sprouting  in paralyzed muscle. 
When combined to previous findings,  our data support the 
notion that muscle IGFs are a central component of intercel- 
lular signaling  in inactivated muscle. 
Application of  lGF-BPs to Block the Biological 
Activities of  IGFs 
IGF-BPs are valuable reagents to interfere with the activity 
of IGFs because  they  are  naturally  occurring  IGF ligands 
with  high  affinity  and  specificity  for these  growth  factors 
(Froesch et al.,  1985; Baxter and Martin,  1989; Yang et al., 
1989;  Clemmons,  1990; Rechler and Nissley,  1990; Rosen- 
feld et al., 1990; Shimasaki and Ling, 1991). The association 
Carop~ et al. Role of Muscle IGFs in Nerve Sprouting  899 Figure  5.  Suppression of terminal nerve sprouting in paralyzed 
mouse gluteus muscle by IGF-BP4. Percentage of endplates with 
sprouts (left) and mean sprout length values (right)  are shown in 
the  figure. Experimental conditions were as  shown in  Fig. 4. 
Animals were sacrificed  7 d after Botulinum  toxin A-induced  paral- 
ysis, and sprouting parameters were derived from silver esterase 
stained cryostat sections. Contents and site of implantation of os- 
motic minipump; (1) no minipump; (2) +IGF-BP4, over paralyzed 
muscle; (3) carrier, but no IGF-BP4, over  paralyzed muscle; (4) 
+IGF-BP4, over contralateral non-paralyzed muscle. Data of ex- 
periments I and 2 are averages and standard deviations from five 
experimental animals (100 endplates per animal); experiments 3 
and 4: average  values from two expe  "nmental  animals each (50 end- 
plates per animal). 
constants of purified recombinant human IGF-BP4 and IGF- 
BP5 for human IGFI and IGF2 are all approximately 2  x 
10  t° M -t (Kiefer et al., 1992).  Affinities for IGF1 and IGF2 
are essentially undistinguishable, indicating that these IGF- 
BPs bind to shared sequences on the two IGFs.  Such se- 
quences are highly conserved in IGFs from man, mouse, and 
chick and represent *70 % of the total mature growth factor 
sequences (Humbel, 1990).  For these reasons, human IGF- 
BP4 and IGF-BP5 probably bind with very similar affinities 
to IGFs from all these vertebrate species. 
The in vitro association constants between the IGF-BPs 
used in this study and IGFs are 10-100-fold higher than those 
between  the  IGFs  and  the  IGFl-receptor  (the  Ir~  of the 
IGFl-receptor for IGFI is 6.7  x  108 M-~; Steele-Perkins et 
al.,  1988).  This receptor tyrosine kinase probably is the 
main transducer of the biological activities of IGFs (Czech, 
1989;  Nissley and Lopaczynski, 1991). As a consequence, 
excess IGF-BP probably prevents extraceUular IGFs from in- 
teraction with cell  surface-associated IGFl-receptor,  thus 
suppressing their biological activities. This prediction was 
verified in several biological assays involving mitogenic and 
differentiating  effects of IGFs (Zapf et al., 1979; Kuoner and 
Smith,  1980;  Mohan et al.,  1989;  Culouscou and Shoyab, 
1991; Kiefer et al., 1992).  It must, however, be pointed out 
that the opposite outcome, i.e., stimulation of IGF activity 
by IGF-BP1,  -3, and -5 was also reported in a limited num- 
ber of cases (Baxter and Martin, 1989;  Clemmons, 1990). 
Stimulatory effects  of IGF-BPs  may  require  special  ex- 
perimental conditions to be detected, and may possibly in- 
volve binding of the IGF/IGF-BP complex to extracellular 
matrix. Thus, in a recent report, Clemmons et al. demon- 
strated that IGF-BP5 binds to cell surfaces and extracellular 
matrix  components,  and  that  such  binding  significantly 
reduces  its  affinity for IGFs  (Jones  et al.,  1993).  These 
authors therefore suggested that IGF-BP5 may serve as a 
delivery system to concentrate and release extracellular IGFs 
to  the IGFl-receptor on  cell  surfaces.  Overall,  however, 
while IGF-BPs clearly prolong the half-life of  IGFs, and may 
potentiate their actions under special conditions, it is clear 
that in most cases excess IGF-BPs in the extracellular space 
prevent the activation of IGF-receptors by IGFs. 
While the effects of  IGF-BPs on IGF activities in vitro have 
been  studied  extensively,  sufficient  mounts  of purified 
recombinant IGF-BPs for in vivo experiments have only re- 
cently become available. In one report, intrabursal adminis- 
tration of  IGF-BP3 in gonadotropin-treated immature female 
rats prevented follicle rupture,  but not oocyte maturation 
(Bicsak et al., 1991). We recently found  that the proliferation 
of muscle interstitial cells, one of the earliest events after 
muscle inactivation, is largely prevented by repeated local 
applications of IGF-BP5 (Caroni and Schneider, 1994). The 
experiments presented in this report demonstrate that local 
effects of  IGF-BPs can be obtained in in vivo experiments ex- 
tending over a period of a week. We noticed, however, that 
interference with intramuscular nerve sprouting was only 
effective when the IGF-BP was applied continuously with an 
osmotic minipump, and that daily applications had little in- 
hibitory effect (Caroni, P., and C.  Schneider, unpublished 
results). This may be due to a limited half-life of the IGF-BP 
in these in vivo experiments, although alternative explana- 
tions, e.g., rapid diffusion away from the site of application 
are also possible. 
Our findings clearly indicate that the 26-kD IGF-BP4 did 
diffuse into the ipsilateral gluteus muscle, and that systemic 
diffusion was not sufficient to  affect intramuscular nerve 
sprouting in the corresponding contralateral muscle. In addi- 
tion, neurite outgrowth assays with muscle extracts from 
IGF-BP4-treated paralyzed muscle provide further evidence 
indicating that IGF-BP4 did diffuse into the gluteus muscle, 
where it bound to IGFs. When compared to those from para- 
lyzed, but otherwise untreated muscles, such extracts were 
significantly  less effective in inducing neurite outgrowth and 
growth cone spreading, suggesting that the IGF-BP4 applied 
in vivo reduced the fraction of active IGF in the paralyzed 
muscles (data not shown). 
IGF-BP-3  and -5 are expressed in muscle (McCusker et 
al., 1989; Peter, M., and J. Zapf, unpublished results), and 
the expression of IGFs and their binding proteins  is  fre- 
quently coordinated and controlled by feedback mechanisms 
(Ceda et al.,  1991; Neely and Rosenfeld, 1992; Lee et al., 
1992;  Conover et al.,  1993).  Therefore, it will be essential 
to obtain much more detailed information on the expression 
of IGF-BPs in the neuromuscular system, in order to formu- 
late  more  precise  hypotheses on the  actions  of the  IGF 
system  in  neuromuscular  development and  regeneration. 
Furthermore,  the recent discovery of specific proteolytic 
processes that affect the binding activity of the IGF-BPs in- 
trgduces the exciting possibility that the actions of the IGFs 
may be modulated locally in the extracellular space (Camp- 
bell et al.,  1992;  Conover et al.,  1993). 
In conclusion, although the local biological roles of IGF- 
BPs may be complex and are presently not clear, our experi- 
ments indicate that they can be applied as pharmacological 
agents to interfere with the activity of IGFs in vitro and in 
vivo. 
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Sprouting after Paralysis 
Our experiments with IGF-BP4 in paralyzed mouse gluteus 
muscle clearly demonstrate that this protein specifically pre- 
vents intramuscular nerve sprouting, indicating that muscle 
IGFs are critically involved in this reaction. The experiments 
with extracts from paralyzed muscle suggest that IGFs are 
a major neurite promoting activity in these muscles. There- 
fore, when combined with previous observations on the time 
course of IGF induction in inactivated skeletal muscle fibers 
(Caroni and Schneider, 1994), and on the effects of IGFs in 
normal and impaired muscle (Caroni and Grandes,  1990; 
Lewis et al., 1993), our results strongly support the conclu- 
sion that muscle IGFs are major components of signaling in 
the inactivated neuromuscular system. 
IGFs may promote nerve sprouting through the activation 
of IGF-receptors on motoneuron processes.  Alternatively, 
activation of IGF-receptors on interstitial cells or the muscle 
fibers themselves may either be necessary or sufficient. Our 
experiments and those of Ishii et al. indicate that IGFs can 
act directly on sensory and motoneurons to promote neurite 
outgrowth in vitro (Recio-Pinto et al.,  1986;  Caronl and 
Grandes,  1990).  In addition, we recently found that when 
applied subcutaneously to skeletal muscle in vivo, IGF1 ac- 
cumulates at the neuromuscular junction (Caronl,  1993). 
This finding suggests that the neuromuscular junction may 
be an important site of action of muscle IGFs. Therefore, a 
direct' mode  of action  of IGFs  on  motoneuron terminal 
branches to induce sprouting seems plausible. It is, however, 
likely that additional cellular reactions, some of them proba- 
bly involving IGFs are also involved in bringing about the ap- 
propriate conditions for effective nerve sprouting (Pestronk 
and Drachman, 1978; Gatchalian et al., 1989; Sanes, 1989). 
Our in vitro experiments suggest that IGFs are an impor- 
tant neurite outgrowth promoting component in paralyzed 
muscle. Thus, IGF1 and extract from paralyzed muscle both 
stimulated neurite outgrowth from dissociated DRG neurons 
in vitro in an IGF-BP4-sensitive manner. We demonstrated 
in a previous report that neurite outgrowth by cultured chick 
spinal motoneurons is strongly promoted by IGFs (Caronl 
and Grandes, 1990). Our experiments now demonstrate that 
protein extracts from paralyzed muscle contain IGF-BP4- 
sensitive neurite-promoting activity for chick and rat spinal 
motoneurons. In addition, 100 ng/ml of IGF-BP4 did not de- 
tectably affect the survival and neurite-promoting activities 
of NGE BDNE  CNTF, or bFGF under our experimental 
conditions. These findings further confirm the high speci- 
ficity of IGF-BP4 for IGFI and IGF2, and strongly suggest 
that this IGF-BP interferes with intramuscular nerve sprout- 
ing in vivo by specifically interacting with IGFs. 
IGFs may not be the only growth factors involved in the 
nerve sprouting reaction in inactivated muscle. Preliminary 
results suggest that the neurotrophin BDNF is upregulated 
in denervated muscle (Henderson, C. E., and A. Rosenthal, 
personal communication). In addition, potent stimulation of 
intramuscular nerve sprouting by local applications of  ciliary 
neurotrophic factor was demonstrated (Gurney et al., 1992). 
Therefore, since a role for additional growth factors in the 
sprouting reaction can presently not be excluded, it is possi- 
ble that although muscle IGFs are required for nerve sprout- 
ing,  restorative  reactions  in  inactivated  muscle  may  be 
produced by multiple growth factors. According to this pos- 
sibility, IGFs in inactivated muscle may promote reactions 
essential for sprouting,  but additional factors may be re- 
quired to induce a sufliciem set of  local changes to effectively 
promote and support intramuscular nerve sprouting. On the 
other hand,  identification and elucidation of the possible 
roles of additional factors in nerve sprouting in inactivated 
muscle will require further in vivo perturbation studies. 
Roles of lGFs and Their Binding Proteins in the 
Neuromuscular System 
IGFs play important roles in muscle growth and differentia- 
tion, and they are the only growth factors known to specifi- 
caUy promote muscle differentiation (Florini et al.,  1991). 
In addition, IGFs appear to be involved in multiple aspects 
of the development and regeneration of the neuromuscular 
system. Expression levels of IGFs during muscle develop- 
ment correlate with the extent of  neuromuscular synaptogen- 
esis, rather than with muscle growth or early differentiation 
(Ishii, 1989). Downregulation of muscle IGFs during devel- 
opment coincides with synapse elimination, and is abolished 
in  Botulinum toxin paralyzed muscle  (Ishii,  1989).  Our 
findings now indicate that muscle IGFs are an essential com- 
ponent of signaling in inactivated adult rodent skeletal mus- 
cle. In addition, recent findings indicate that IGFs may be 
important components in promoting and accelerating pe- 
ripheral nerve regeneration and functional recovery after le- 
sion (Near et al., 1992; Lewis et al., 1993). It therefore ap- 
pears that IGFs may play multiple and important roles in 
neuromuscular development and regeneration. 
In conclusion, while more work is required to understand 
the role of  IGFs in the neuromuscular system, it is clear from 
the results of this and other recent studies that IGFs play 
central roles in regenerative processes of the neuromuscular 
system. These findings may therefore have important impli- 
cations for the study and treatment of  pathologies of the neu- 
romuscular system. 
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